非酒精性脂肪肝合并代谢综合征的相关因素分析

doi:10.3969/j.issn.1004-583X.2019.06.012

临床荟萃

非酒精性脂肪肝合并代谢综合征的相关因素分析

江门市中心医院体检中心，广州江门 529000

出版日期:2019-06-20 发布日期:2019-08-02
通讯作者: 张丽芬, Email: shiyizhangdoctor@163.com

Logistic regression analysis of related factors of nonalcoholic fatty liver combined with metabolic syndrome

Medical Examination Center, Jiangmen Central Hospital, Jiangmen 529000, China

Online:2019-06-20 Published:2019-08-02
Contact: Corresponding author: Zhang Lifen, Email: shiyizhangdoctor@163.com

摘要/Abstract

摘要： 目的探讨非酒精性脂肪肝（NAFLD）合并代谢综合征（MS）的相关因素。方法 2015年1月至2016年12月我院门诊体检及诊断的NAFLD患者422例，按照是否合并MS分为对照组（n=176例）及研究组（n=246例），采用二分类Logistic回归分析NAFLD合并MS的相关影响因素。结果两组年龄、性别、饮酒、体重、BMI、TC、UA、FPG、Fins、HOMAIR、GSH差异有统计学意义（P<0.05）；二分类Logistic回归分析显示，年龄、BMI、HOMAIR、GSH是NAFLD合并MS的相关影响因子。结论 NAFLD与MS关系密切，年龄、BMI、HOMAIR、GSH可作为NAFLD发病后合并MS的相关预测因子。

关键词: 脂肪肝, 代谢综合征, 影响因素

Abstract: Objective To investigate the related factors of nonalcoholic fatty liver (NAFLD) with metabolic syndrome (MS). Methods A total of 422 patients with NAFLD who were examined and diagnosed in our outpatient clinic from January 2015 to December 2016 were divided into the control group (n=176 cases) and the study group (n=246 cases) according to whether MS was combined. Binary logistic was adopted. Regression analysis of the relevant influencing factors of NAFLD combined with MS was performed. Results There were significant differences in age, gender, alcohol consumption, body weight, BMI index, TC, UA, FPG, Fins, HOMAIR and GSH between the two groups (P<0.05). Binary logistic regression analysis showed that age, BMI index, HOMAIR, GSH were the relevant influencing factors of NAFLD combined with MS. Conclusion NAFLD is closely related to MS. Age, BMI index, HOMAIR and GSH can be used as predictors of NAFLD combined with MS.

Key words: Fatty Liver, Metabolic syndrome, Influencing factors

张丽芬，王培燊，刘玲. 非酒精性脂肪肝合并代谢综合征的相关因素分析[J]. 临床荟萃, doi: 10.3969/j.issn.1004-583X.2019.06.012.

Zhang Lifen, Wang Peiyu, Liu Ling. Logistic regression analysis of related factors of nonalcoholic fatty liver combined with metabolic syndrome[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2019.06.012.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2019.06.012

https://huicui.hebmu.edu.cn/CN/Y2019/V34/I6/545

[1]	梁炳松, 李育英, 张岐平, 陈英道, 李健. 替罗非班治疗进展性穿支动脉梗死临床疗效的相关因素[J]. 临床荟萃, 2023, 38(12): 1091-1094.
[2]	白碧玥, 彭艳, 朱晓峰, 尹昌浩. 缺血性脑卒中影响侧支循环建立因素的研究进展[J]. 临床荟萃, 2023, 38(11): 1034-1037.
[3]	曲军民, 杨丽敏, 原风英. 躯体症状障碍患者抗抑郁药治疗依从性的影响因素分析[J]. 临床荟萃, 2022, 37(3): 266-270.
[4]	冯媛, 李萍, 郑佳佳, 臧佳佳, 平芬. 新冠疫情背景下哮喘患者心理状态及影响因素[J]. 临床荟萃, 2022, 37(3): 275-278.
[5]	张宏涛, 王志奎. 单中心维持性腹膜透析患者肾性贫血现况及相关因素分析[J]. 临床荟萃, 2022, 37(12): 1099-1103.
[6]	赵薇, 罗兰, 李珅, 董莹莹, 李欣宇, 高政南. TG/HDL-C、 TyG、 non-HDL-C预测中老年女性代谢综合征价值[J]. 临床荟萃, 2021, 36(9): 790-794.
[7]	鲁奎, 郑龙. 急性脑梗死DWI阴性原因分析[J]. 临床荟萃, 2021, 36(8): 753-756.
[8]	高莉, 褚璇. 达格列净联合利拉鲁肽治疗2型糖尿病伴代谢综合征患者临床疗效[J]. 临床荟萃, 2021, 36(7): 616-619.
[9]	叶菁菁, 秦瑜, 赵丽, 杨玲. 身体形态指数与新诊2型糖尿病合并非酒精性脂肪肝的关系[J]. 临床荟萃, 2021, 36(2): 144-148.
[10]	张琴, 王淑彬, 苏璇, 袁睿, 高萌晞, 国丽茹. 社区缺血性脑卒中患者遗留功能障碍现况及其影响因素[J]. 临床荟萃, 2021, 36(12): 1073-1078.
[11]	张莹, 王春生. 降脂利肝颗粒联合辛伐他汀治疗NAFLD对肝生化指标、瘦素及脂联素的影响[J]. 临床荟萃, 2021, 36(1): 58-61.
[12]	梁欢1，刘建凤2. 盘点钠-葡萄糖协同转运蛋白2抑制剂临床研究新进展[J]. 临床荟萃, 2020, 35(9): 861-864.
[13]	翟谨1, 2，徐俊1，何萍1，花盛浩1，丰涛1. 儿童Epstein-Barr 病毒合并肺炎支原体感染的临床特点[J]. 临床荟萃, 2020, 35(2): 174-176.
[14]	黄德波，林传行，周远方，毛献泉，许福观. 支架取栓治疗急性大动脉闭塞性脑梗死预后的影响因素分析[J]. 临床荟萃, 2020, 35(1): 41-46.
[15]	罗兰，牛敏，张楠，高政南. 脂质蓄积指数在中老年人群代谢综合征筛查中的价值[J]. 临床荟萃, 2019, 34(3): 231-236.

非酒精性脂肪肝合并代谢综合征的相关因素分析

Logistic regression analysis of related factors of nonalcoholic fatty liver combined with metabolic syndrome

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价